RE:RE:RE:RE:Bad news must be on its way 🤡 WOW! Solid reply, Tommy???
What chart(s) are you referring to? The one that shows the sp consistently around $.16 or between $.15 and $.20 for over 3 months now? You, of course, didn't answer, nor have provided a fact based account to anyone else, of your magic number $.07 sp.
The first Venowave devices were not shipped (because of supply chain delays ....and the recent covid lockdown in China) until one month ago. So of course they're not part of any quarterly financials released to date ...do you actually read the NRs, follow the stock and do even a modicum of DD? The last financials were for the quarter ending January 31, 2022. It is quite conceivable based on the NR on April 28, 2022 concerning the shipment of the first devices that any revenue related to this won't even show up on the next quarterly report but will almost certainly be referenced in the MD&A for that period.
Don't bother responding if you can't put together anything more than a grade school response.
Cheers!!!
TomConstantine wrote: The charts tell it all. Plus where are you going to sell test kits? Look at the financials and tell me how "venowave" is doing.